Hunterbrook Media released a short report on diabetes-focused DexCom Inc. (NASDAQ:DXCM), citing that the company sold the "adulterated" device. Benzinga reached out to DexCom for comments and is yet ...
Dexcom, Inc, has issued a recall for G7 Apps and ONE+ Apps because of a software design error failing to alert users of unexpected sensor failures. This recall ...
The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users. Taylor Leamey wrote about all things wellness for CNET, specializing in ...
Dexcom was hit with a consumer class action on Oct. 15 in California Central District Court over alleged defects in its G7 Continuous Glucose Monitoring System. The lawsuit, brought by Cowper Law and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results